Amedeo Smart

Free Medical Literature Service

 

Amedeo

Inflammatory Bowel Diseases
  Free Subscription

Articles published in
Z Gastroenterol
    March 2026
  1. STEIN J, Schroeder O, Tessmer L, Muller E, et al
    [Obesity meets Inflammatory Bowel Disease - a Double Whammy? A narrative Review].
    Z Gastroenterol. 2026;64:283-299.
    >> Share

    February 2026
  2. ALEXANIDOU E, Horning A, de Laffolie J, Schmidt-Choudhury A, et al
    [Crohn's Disease Exclusion Diet (CDED) and partial enteral nutrition (PEN) for remission induction in children and adolescents with Crohn's Disease - Updated statement from the CEDATA and Nutrition/Dietetics/Nutritional Medicine Working Groups of the
    Z Gastroenterol. 2026;64:184-198.
    >> Share

  3. ALEXANIDOU E, Horning A, de Laffolie J, Schmidt-Choudhury A, et al
    [Correction: Crohn's Disease Exclusion Diet (CDED) and partial enteral nutrition (PEN) for remission induction in children and adolescents with Crohn's Disease - Updated statement from the CEDATA and Nutrition/Dietetics/Nutritional Medicine Working Gr
    Z Gastroenterol. 2026;64:e85.
    >> Share

    January 2026
  4. POKRYSZKA J, Primas C, Stadlmann M, Gerold N, et al
    Post-induction serum vedolizumab levels are not associated with better maintenance outcomes in patients with Crohn's disease.
    Z Gastroenterol. 2026 Jan 12. doi: 10.1055/a-2744-5136.
    >> Share

  5. ZECHER BF, Schramm C
    [Immunopathogenesis and therapy of primary sclerosing cholangitis].
    Z Gastroenterol. 2026;64:56-66.
    >> Share

    October 2025
  6. SCHNOY E, Dignass A, Gaskins M, Kucharzik T, et al
    Correction: From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.
    Z Gastroenterol. 2025;63:e668-e669.
    >> Share

    June 2025
  7. SCHNOY E, Dignass A, Gaskins M, Kucharzik T, et al
    From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.
    Z Gastroenterol. 2025 Jun 16. doi: 10.1055/a-2596-8934.
    >> Share

    May 2025
  8. PUESCHEL L, Hupa-Breier K, Wedemeyer H, Lenzen H, et al
    Food-related Quality of Life in patients with Inflammatory Bowel Disease: Translation and Validation of the German version of FR-QoL-29.
    Z Gastroenterol. 2025;63:477-485.
    >> Share

    March 2025
  9. DABRITZ J, Classen M, Krohn K, Krahl A, et al
    [Position paper of the Society for Paediatric Gastroenterology and Nutrition (GPGE) on the off-label use of biologics and signal inhibitors in children and adolescents with IBD that have already been approved for adults].
    Z Gastroenterol. 2025;63:255-268.
    >> Share

  10. REINER J, Becker AS, Huth A, Lamprecht G, et al
    Mirikizumab for the treatment of chronic antibiotic-refractory pouchitis.
    Z Gastroenterol. 2025;63:269-272.
    >> Share

    November 2024
  11. WEI X, Tang D
    Effect of Bacteroides on Crohn's disease.
    Z Gastroenterol. 2024 Nov 25. doi: 10.1055/a-2435-2659.
    >> Share

  12. DIETMAIER L, Summa S, Ronicke M, Erfurt-Berge C, et al
    Peristomal skin lesions - identifying patients at risk.
    Z Gastroenterol. 2024;62:1924-1930.
    >> Share

    August 2024
  13. STURM A, Atreya R, Bettenworth D, Bokemeyer B, et al
    [Not Available].
    Z Gastroenterol. 2024;62:1229-1318.
    >> Share

  14. LORENZ P, Stallmach A, Sturm A, Lynen Jansen P, et al
    [Not Available].
    Z Gastroenterol. 2024;62:e531-e536.
    >> Share

    May 2024
  15. KUCHARZIK T, Dignass A, Atreya R, Bokemeyer B, et al
    [Not Available].
    Z Gastroenterol. 2024;62:769-858.
    >> Share

  16. LORENZ P, Dignass A, Kucharzik T, Jansen PL, et al
    [Not Available].
    Z Gastroenterol. 2024;62:e470-e476.
    >> Share

    April 2024
  17. STRATMANN K, Hentschel V, Zeuzem S, Blumenstein I, et al
    [Iron supplementation in patients with chronic inflammatory bowel disease: recommendations for a practical approach].
    Z Gastroenterol. 2024 Apr 24. doi: 10.1055/a-2274-1610.
    >> Share

  18. SCHMIDT C, Stallmach A, Sturm A, Bachmann O, et al
    [Update: Addendum to S3-Guidelines Crohn disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease with regard to COVID-19 (version 2.0)].
    Z Gastroenterol. 2024;62:517-534.
    >> Share

    February 2024
  19. KOLLECKER T, Nistal M, Waltz V, Ehard F, et al
    [Takayasu arteritis after COVID-19 infection in a 26-year-old female patient with Crohn's disease].
    Z Gastroenterol. 2024 Feb 28. doi: 10.1055/a-2187-9295.
    >> Share

  20. HAFNER S, Seufferlein T, Kleger A, Muller M, et al
    Symptoms and Management of Aseptic Liver Abscesses.
    Z Gastroenterol. 2024;62:208-217.
    >> Share

    November 2023
  21. REIDER S, Novacek G, Haas T, Grochenig HP, et al
    [Use of subcutaneous Vedolizumab: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (OGGH)].
    Z Gastroenterol. 2023;61:1518-1525.
    >> Share

    October 2023
  22. MOLL-VON DER WETTERN M, Heinlein W, Rathmayer M, Koller L, et al
    [A critical DRG-evaluation of cases with inflammatory bowel disease].
    Z Gastroenterol. 2023 Oct 12. doi: 10.1055/a-2075-2533.
    >> Share

    September 2023
  23. DEMMER S, Kleindienst N, Hjortswang H, Thomann P, et al
    Validation of the German version of the Short Health Scale - a brief, valid and reliable instrument to assess health-related quality of life in German-speaking patients with inflammatory bowel diseases.
    Z Gastroenterol. 2023;61:1207-1213.
    >> Share

    August 2023
  24. KUCHARZIK T, Dignass A, Atreya R, Bokemeyer B, et al
    [Not Available].
    Z Gastroenterol. 2023;61:1046-1134.
    >> Share

  25. KUCHARZIK T, Dignass A
    [Not Available].
    Z Gastroenterol. 2023;61:1000-1001.
    >> Share

  26. LORENZ P, Dignass A, Kucharzik T, Fischer N, et al
    [Not Available].
    Z Gastroenterol. 2023;61:e358-e364.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016